BPA Call 75H71224A00011-75H71224F28001
Award Date 6/28/24
Potential Completion Date 6/16/29
Potential Value $177K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Phoenix, AZ 85016, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Indian Health Service awarded a Blanket Purchase Agreement (BPA) call valued at $181.4K to Meridian Bioscience Inc. for laboratory supplies and extended warranty services under the Year-2 BPA Call 24A00011-25F28002. This firm fixed-price contract, which includes a correction to unit pricing for identification kits, will be performed in Phoenix, Arizona, with an ultimate completion date of June 16, 2026. The award was made without a set-aside designation, reflecting Meridian Bioscience's...
- This is a firm-fixed-price Blanket Purchase Agreement (BPA) call order awarded by the U.S. Department of the Air Force Materiel Command to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic substances, reagents, test kits, and sets. The $167,063 contract provides clinical diagnostic products and supplies to support federal health and screening programs. Meridian Bioscience has previously delivered COVID-19 tests, lead testing systems, hepatitis assays,...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call awarded by the Department of the Air Force Materiel Command to Meridian Bioscience Inc., a foreign-owned for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The $154,150.00 contract is for the delivery of in vitro diagnostic substances, reagents, test kits, and sets, with a period of performance ending on September 30, 2018. There was no set-aside designation used for this award. Meridian Bioscience...
- This is a firm-fixed-price purchase order contract awarded by the U.S. Department of Defense, Bureau of Medicine and Surgery, to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The contract, valued at $30,875.64, is for the procurement of ILLUMIGEN GBS KIT and does not have a set-aside designation. Meridian Bioscience Inc. is a key supplier of diagnostic solutions to various federal agencies, including the Department...
- This federal contract award to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments, is for the provision of laboratory reagents for the Centers for Disease Control and Prevention (CDC) Pittsburgh facility. The contract, valued at $49,466.00, is a firm fixed-price purchase order with an ultimate completion date of November 1, 2024. The contract does not have a set-aside designation. Meridian Bioscience is a key supplier of...
- This is a definitive contract awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Meridian Bioscience Inc., a foreign-owned, for-profit manufacturer of in vitro diagnostic test kits, reagents, and instruments. The contract, valued at $274,884.11, is for the supply of "PREMIER PLATINUM HPSA PLUS KITS" with a completion date of September 30, 2021. The contract is a firm fixed-price arrangement. Meridian Bioscience Inc. is a key supplier of diagnostic solutions to...
- This is a BPA Call contract awarded by the Indian Health Service, a civilian agency, to Biomerieux Inc. for $172,680.00. The contract is for the provision of test kits and quality control products, with a period of performance running until March 26, 2026. The contract does not have a set-aside designation. Biomerieux Inc., a global leader in in vitro diagnostics, will be the prime contractor providing its specialized diagnostic platforms, reagents, and test kits to support infectious disease...
- Indian Health Service issued a BPA call to Meridian Bioscience Inc. on June 17, 2026, for laboratory supplies with a ceiling value of $186,290. The call is issued under the Indian Health Service BPA for the BREATH ID Smart System, which provides diagnostic testing equipment, associated supplies, and extended warranty services through June 2029. Performance occurs in Phoenix, Arizona, with an ultimate completion date of June 16, 2027. The supplies are procured on a firm fixed price basis with...
- This is a firm-fixed-price Blanket Purchase Agreement (BPA) call order awarded by the Indian Health Service (IHS) to Biomerieux Inc., a global manufacturer of in vitro diagnostic products and services. The $1,216,476 contract is for the procurement of BioFire panel reagents, which are used in the agency's infectious disease testing and pathogen detection operations. This order is placed under a larger $194 million Federal Supply Schedule contract held by Biomerieux for In Vitro Diagnostics,...
- The U.S. Department of Health and Human Services, Indian Health Service (IHS) awarded a Blanket Purchase Agreement (BPA) call contract modification to Biomerieux Inc. through its Biomerieux, Inc. division, a global leader in in vitro diagnostics. The contract, valued at $13,419.85, provides for the supply of Biomerieux's specialized diagnostic platforms, reagents, and test kits to support infectious disease testing and pathogen detection across IHS healthcare operations. This BPA contract is...